CN103110807B - Medicine for treating diabetes - Google Patents
Medicine for treating diabetes Download PDFInfo
- Publication number
- CN103110807B CN103110807B CN201310061431.4A CN201310061431A CN103110807B CN 103110807 B CN103110807 B CN 103110807B CN 201310061431 A CN201310061431 A CN 201310061431A CN 103110807 B CN103110807 B CN 103110807B
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma
- diabetes
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to a medicine for treating diabetes. The medicine is prepared from the following traditional Chinese medicinal materials by weight: 15g of Codonopsis pilosula, 30g of Astragalus mongholicus, 15g of the root of red-rooted salvia, 15g of Chinese yam, 15g of Rhizoma Atractylodis Macrocephalae, 10g of radices trichosanthis, 15g of radix paeoniae alba, 10g of glossy privet fruit, 10g of the root of straight ladybell, 15g of Radix Ophiopogonis, 10g of rhizoma anemarrhenae, 15g of Ligusticum wallichii, 115g of ramulus euonyrni, 6g of Pinellia ternate, 10g of tortoise shell, 10g of turtle shell, 15g of hawthorn and 10g of pericarpium citri reticulatae. The medicine provided by the invention is a pure traditional Chinese medical preparation which is scientific in proportion, treats both symptoms and root causes, and has remarkable curative effect to diabetes through clinical verifications.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of diabetes, be specifically related to a kind of medicine of the treatment diabetes that are prepared from by Chinese herbal medicine.
Background technology
Diabetes are a kind of common, multiple chronic diseases, serious harm human health and quality of life, the treatment of diabetes is long-term processes, and its treatment is not to be merely object in order to reduce blood glucose, the more important thing is and change life quality and delay complication, avoid the infringement of internal organs.The treatment doctor trained in Western medicine of diabetes generally adopts antidiabetic drug, this curative effect of medication is definite, in the time for the treatment of, often there is the untoward reaction such as hypoglycemia, Chinese medicine is because have dual regulation, there will not be hypoglycemia and more and more accepted and like by diabetics, but the Chinese medicine of the treatment diabetes of determined curative effect is less, cannot meet the needs of clinical treatment.
Summary of the invention
In order to solve the problems of the technologies described above, the invention provides a kind of medicine for the treatment of diabetes.This medicine is pure Chinese medicinal preparation, and determined curative effect, has no side effect.
Technical scheme of the present invention is as follows: a kind of medicine for the treatment of diabetes, Chinese crude drug by following weight portion is prepared from: Radix Codonopsis 15g, Radix Astragali 30g, Radix Salviae Miltiorrhizae 15g, Rhizoma Dioscoreae 15g, Rhizoma Atractylodis Macrocephalae 15g, Radix Trichosanthis 10g, Radix Paeoniae Alba 15g, Fructus Ligustri Lucidi 10g, Radix Adenophorae (Radix Glehniae) 10g, Radix Ophiopogonis 15g, Rhizoma Anemarrhenae 10g, Rhizoma Chuanxiong 15g, Ramulus Euonymi 15g, Rhizoma Pinelliae 6g, Carapax Et Plastrum Testudinis 10g, Carapax Trionycis 10g, Fructus Crataegi 15g, Pericarpium Citri Reticulatae 10g.
Preparation method: get above each taste, add the decocting of 10 times, 8 times amounts to boil 2 times, each 2 hours, merging filtrate, was concentrated into 200ml for subsequent use.
Medicine of the present invention adopts pure Chinese medicinal preparation, science compatibility, and treating both the principal and secondary aspects of a disease, has significant curative effect through clinical verification to diabetes.
Clinical data
1, case source
Choose altogether case 100 examples, be divided into immediately 2 groups, treatment group 50 examples, wherein male 31 examples, female's 19 examples, the age between 30-70 year, course of disease 1-30; Male 30 examples in matched group 50 examples, female's 20 examples, between age 32-71 year, course of disease 1-28.2 groups of clinical datas, relatively without difference, have comparability.More than include case in and all meet the diabetes diagnosis standard that WHO formulates.
2, Therapeutic Method
Treatment group gives oral medicine of the present invention, and a prescription is potion, and potion on the one divides and takes for three times, within one month, is a course for the treatment of, after 3 courses for the treatment of, evaluates curative effect.
Matched group obese type is with metformin 30 mg/ time, and oral, 3 times/d, thin type takes diamicron, and 80 rag/ time, 2 times/d.The oral acarbose of the higher person of post-prandial glycemia, 50 mg/ time, 3 times/d.Take January as 1 course for the treatment of, treat and evaluate curative effect 3 courses for the treatment of.
3, observation index
Main clinic symptoms, fasting glucose (FBG), after the meal 2 hours blood glucoses (P2BG) before and after treatment.
4, criterion of therapeutical effect
With reference to " new Chinese medicine guideline of clinical investigations " relevant criterion of therapeutical effect.Effective: clinical symptoms, sign are obviously improved, disease integration reduces >=70%, FBG, P2BG and drops to normal range, or FBG, P2BG decline exceedes 30% before treatment; Effective: clinical symptoms, sign all take a favorable turn, disease integration reduces >=30%; FBG, P2BG decline and exceed 20.00% before treatment, but do not reach effective standard; Invalid: FBG, P2BG are without decline, or decline does not reach effective standard.
5, therapeutic outcome
Effective 22 examples for the treatment of group, effective 24 examples, invalid 4 examples, total effective rate 92%.Effective 20 examples of matched group, effective 27 examples, invalid 5 examples, total effective rate 90%.Illustrate that medicine of the present invention is better than Western medicine, there is significant blood sugar lowering curative effect.FBG, P2BG comparison before and after 2 groups of treatments,, the results are shown in following table.
As can be seen from the above data, the therapeutic effect of medicine of the present invention and western medicine group, without significant difference, all have significant curative effect.Illustrate that medicine of the present invention equally has significant curative effect with Western medicine.
the specific embodiment
Below in conjunction with embodiment, the present invention is further illustrated.
embodiment 1
Get Radix Codonopsis 15g, Radix Astragali 30g, Radix Salviae Miltiorrhizae 15g, Rhizoma Dioscoreae 15g, Rhizoma Atractylodis Macrocephalae 15g, Radix Trichosanthis 10g, Radix Paeoniae Alba 15g, Fructus Ligustri Lucidi 10g, Radix Adenophorae (Radix Glehniae) 10g, Radix Ophiopogonis 15g, Rhizoma Anemarrhenae 10g, Rhizoma Chuanxiong 15g, Ramulus Euonymi 15g, Rhizoma Pinelliae 6g, Carapax Et Plastrum Testudinis 10g, Carapax Trionycis 10g, Fructus Crataegi 15g, Pericarpium Citri Reticulatae 10g, add the decocting of 10 times, 8 times amounts to boil 2 times, each 2 hours, merging filtrate, was concentrated into 200ml for subsequent use.
Claims (1)
1. treat the medicine of diabetes for one kind, it is characterized in that, Chinese crude drug by following weight portion is prepared from: Radix Codonopsis 15g, Radix Astragali 30g, Radix Salviae Miltiorrhizae 15g, Rhizoma Dioscoreae 15g, Rhizoma Atractylodis Macrocephalae 15g, Radix Trichosanthis 10g, Radix Paeoniae Alba 15g, Fructus Ligustri Lucidi 10g, Radix Adenophorae (Radix Glehniae) 10g, Radix Ophiopogonis 15g, Rhizoma Anemarrhenae 10g, Rhizoma Chuanxiong 15g, Ramulus Euonymi 15g, Rhizoma Pinelliae 6g, Carapax Et Plastrum Testudinis 10g, Carapax Trionycis 10g, Fructus Crataegi 15g, Pericarpium Citri Reticulatae 10g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310061431.4A CN103110807B (en) | 2013-02-27 | 2013-02-27 | Medicine for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310061431.4A CN103110807B (en) | 2013-02-27 | 2013-02-27 | Medicine for treating diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103110807A CN103110807A (en) | 2013-05-22 |
| CN103110807B true CN103110807B (en) | 2014-05-28 |
Family
ID=48409213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310061431.4A Expired - Fee Related CN103110807B (en) | 2013-02-27 | 2013-02-27 | Medicine for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103110807B (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101007137A (en) * | 2007-01-24 | 2007-08-01 | 张光珍 | 'Qimailing' oral liquid and its preparation method |
| CN101120985A (en) * | 2006-08-08 | 2008-02-13 | 芮育健 | New use of traditional Chinese medicines codonopsis pilosulae, radix astragali, and haw for spleen-strengthening, heat-dispersing and treating diabetes |
| CN101125177A (en) * | 2007-08-15 | 2008-02-20 | 朱序金 | Fermented glutinous wine for treating diabetes |
| CN101284015A (en) * | 2008-05-05 | 2008-10-15 | 济南康众医药科技开发有限公司 | Medicine for treating diabetes and production method thereof |
| CN102188613A (en) * | 2011-05-16 | 2011-09-21 | 纳正林 | Traditional Chinese medicine preparation for treating diabetes |
| CN102671118A (en) * | 2012-04-25 | 2012-09-19 | 王伟 | Traditional Chinese medicine for treating diabetes mellitus and method for preparing same |
-
2013
- 2013-02-27 CN CN201310061431.4A patent/CN103110807B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101120985A (en) * | 2006-08-08 | 2008-02-13 | 芮育健 | New use of traditional Chinese medicines codonopsis pilosulae, radix astragali, and haw for spleen-strengthening, heat-dispersing and treating diabetes |
| CN101007137A (en) * | 2007-01-24 | 2007-08-01 | 张光珍 | 'Qimailing' oral liquid and its preparation method |
| CN101125177A (en) * | 2007-08-15 | 2008-02-20 | 朱序金 | Fermented glutinous wine for treating diabetes |
| CN101284015A (en) * | 2008-05-05 | 2008-10-15 | 济南康众医药科技开发有限公司 | Medicine for treating diabetes and production method thereof |
| CN102188613A (en) * | 2011-05-16 | 2011-09-21 | 纳正林 | Traditional Chinese medicine preparation for treating diabetes |
| CN102671118A (en) * | 2012-04-25 | 2012-09-19 | 王伟 | Traditional Chinese medicine for treating diabetes mellitus and method for preparing same |
Non-Patent Citations (2)
| Title |
|---|
| 倪玉心.用中西医结合法治疗2型糖尿病的临床观察.《求医问药》.2012,第10卷(第11期),第1037页. |
| 用中西医结合法治疗2型糖尿病的临床观察;倪玉心;《求医问药》;20121130;第10卷(第11期);第1037页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103110807A (en) | 2013-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102274447B (en) | Medicinal composition for treating diabetes | |
| CN103083531A (en) | Drug for treating diabetes | |
| CN102205090B (en) | Chinese medicinal stagnancy-removing and stagnation-eliminating soup for treating liver depression qi stagnation type indigestion | |
| CN102872425B (en) | Traditional Chinese medicine decoction for treating climacteric syndrome | |
| CN101112510A (en) | Pearl soup Chinese traditional medicine for treating hyperkinetic symptom | |
| CN100493572C (en) | Composition of medication for treating diabetes | |
| CN104001035A (en) | Trichosanthis Radix and Radix Puerariae-containing traditional Chinese medicinal preparation for treating type 2 diabetes mellitus | |
| CN102462834A (en) | Medicinal composition for controlling blood sugar of diabetic | |
| CN103446503A (en) | Traditional Chinese medicine composition for treating type II diabetes mellitus | |
| CN102225190A (en) | Traditional Chinese preparation for treating chronic colitis | |
| CN102274479B (en) | Traditional Chinese medicine composition for treating functional dyspepsia | |
| CN102698058B (en) | Health care extract for adjusting sub-healthy state of human body | |
| CN102526635B (en) | Medicament for treating premenstrual stress syndrome and preparation method thereof | |
| CN102205030B (en) | Chinese medical female-benefiting and menstruation-regulating soup for treating polycystic ovary syndrome | |
| CN103301438A (en) | Traditional Chinese medicine composition for treating gastroptosis and preparation method thereof | |
| CN103845656A (en) | Medicament for treating chronic colitis of weakness of spleen and stomach type | |
| CN103071070A (en) | Traditional Chinese medicine formula for treating recurrent aphthous ulcer | |
| CN104013806A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN109663068A (en) | A kind of drug and preparation method thereof for acute exacerbation of chronic obstructive pulmonary disease | |
| CN103110807B (en) | Medicine for treating diabetes | |
| CN101057961A (en) | Medicine decoction for treating breast addiction of stagnation of liver-qi type and its preparation method | |
| CN103251827A (en) | Traditional Chinese medicine composition for treating diabetes mellitus and preparation method thereof | |
| CN102302744B (en) | Chinese medicinal preparation for treating chronic cholecystitis | |
| CN104721580A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN103263595A (en) | Traditional Chinese medicine composition for treating diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140528 Termination date: 20150227 |
|
| EXPY | Termination of patent right or utility model |